Belcaro, Gianni, Luzzi, Roberta, Hosoi, Morio et al. · Minerva medica · 2018 · DOI
This study looked at whether a plant-based supplement called Robuvit® could help people with PTSD (post-traumatic stress disorder) recover faster alongside standard therapy. Over 4 weeks, people who took Robuvit® along with therapy showed greater improvements in symptoms like intrusive memories, nightmares, flashbacks, sleep problems, and fatigue compared to those who received therapy alone.
Since ME/CFS and PTSD share overlapping symptom profiles—including fatigue, sleep disturbance, emotional dysregulation, and elevated oxidative stress—findings about interventions that address these mechanisms in PTSD may inform understanding of symptom management strategies in ME/CFS. The potential role of oxidative stress reduction in both conditions merits investigation.
This study does not prove that Robuvit® is effective for ME/CFS, as the population studied (earthquake survivors with PTSD) differs fundamentally from ME/CFS patients. The absence of a placebo control group and randomization means improvement could reflect placebo effect, natural recovery, or differences in patient expectations rather than the supplement's pharmacological action. Correlation between oxidative stress reduction and symptom improvement was not directly measured.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →